Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

Market Cap	2.12B -45.4%
Revenue (ttm)	612.37M -42.4%
Net Income	-421.71M
EPS	-1.05
Shares Out	400.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	806,100
Open	5.33
Previous Close	5.39
Day's Range	5.28 - 5.38
52-Week Range	5.15 - 10.32
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:605199

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of digestive system, respiratory system, anti- infective, anti-virus and other fields in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 2,103
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605199

Financial Performance

In 2025, SHA:605199's revenue was 900.84 million, a decrease of -36.27% compared to the previous year's 1.41 billion. Losses were -287.37 million, 4.71% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error